Literature DB >> 7899248

Enantioselective kinetics of verapamil and norverapamil in isolated perfused rat livers.

R Mehvar1, J M Reynolds, M A Robinson, J A Longstreth.   

Abstract

The kinetics of the individual enantiomers of verapamil (VER) and its metabolite, norverapamil (NOR), were studied in isolated perfused rat livers (IPRLs) after administration of racemic drug or the preformed metabolite. After constant infusion of 20 micrograms/min of racemic VER to single-pass IPRLs, the hepatic availabilities (F) of the enantiomers were low (S-VER, 0.069 +/- 0.030; R-VER: 0.046 +/- 0.025) and stereoselective (S:R ratio, 1.6 +/- 0.2). After administration of similar doses, the F values of the preformed NOR enantiomers (S-NOR: 0.24 +/- 0.04; R-NOR, 0.10 +/- 0.02) were higher than those of the VER enantiomers. However, the stereoselectivity in F of NOR (S:R ratio, 2.2 +/- 0.1), was in the same direction of that of VER. Further, the fractions of R enantiomers unbound to bovine serum albumin in the perfusate were higher than those of their antipodes for both VER (R:S ratio, 1.9 +/- 0.1) and NOR (R:S ratio, 2.6 +/- 0.2). Therefore, for unbound moieties, modest stereoselectivity in the metabolism of VER in favor of the S-isomer and no stereoselectivity in the metabolism of NOR were observed. Overall, our data suggest that the stereoselective protein binding is a primary determinant of stereoselectivity in the hepatic availability of VER and NOR in IPRLs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7899248     DOI: 10.1023/a:1018935921473

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Commentary: a physiological approach to hepatic drug clearance.

Authors:  G R Wilkinson; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram.

Authors:  R G McAllister; D W Bourne; L W Dittert
Journal:  J Pharmacol Exp Ther       Date:  1977-07       Impact factor: 4.030

3.  Electrophysiologic effects of dextro- and levo-verapamil on sinus node and AV node function in humans.

Authors:  H Echizen; M Manz; M Eichelbaum
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

4.  Mechanisms of time-dependent kinetics of diltiazem in the isolated perfused rat liver.

Authors:  M D Hussain; Y K Tam; M R Gray; R T Coutts
Journal:  Drug Metab Dispos       Date:  1994 Jan-Feb       Impact factor: 3.922

5.  Physiological pharmacokinetics and pharmacodynamics of (+/-)-verapamil in female rats.

Authors:  E L Todd; D R Abernethy
Journal:  Biopharm Drug Dispos       Date:  1987 May-Jun       Impact factor: 1.627

6.  Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration.

Authors:  D R Abernethy; I W Wainer; J A Longstreth; N S Andrawis
Journal:  J Pharmacol Exp Ther       Date:  1993-08       Impact factor: 4.030

7.  The pharmacokinetics and pharmacodynamics of d- and dl-verapamil in rabbits.

Authors:  J C Giacomini; W L Nelson; L Theodore; F M Wong; D Rood; K M Giacomini
Journal:  J Cardiovasc Pharmacol       Date:  1985 May-Jun       Impact factor: 3.105

8.  Intravenous verapamil kinetics in rats: marked arteriovenous concentration difference and comparison with humans.

Authors:  P Manitpisitkul; W L Chiou
Journal:  Biopharm Drug Dispos       Date:  1993-10       Impact factor: 1.627

9.  Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique.

Authors:  B Vogelgesang; H Echizen; E Schmidt; M Eichelbaum
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

10.  Enantioselective N-oxygenation of verapamil by the hepatic flavin-containing monooxygenase.

Authors:  J R Cashman
Journal:  Mol Pharmacol       Date:  1989-09       Impact factor: 4.436

View more
  5 in total

1.  Determination of R(+)- and S(-)-lansoprazole using chiral stationary-phase liquid chromatography and their enantioselective pharmacokinetics in humans.

Authors:  H Katsuki; H Yagi; K Arimori; C Nakamura; M Nakano; S Katafuchi; Y Fujioka; S Fujiyama
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

2.  Development and application of an isolated perfused rat liver model to study the stimulation and inhibition of tumor necrosis factor-alpha production ex vivo.

Authors:  Reza Mehvar; Xiaoping Zhang
Journal:  Pharm Res       Date:  2002-01       Impact factor: 4.200

Review 3.  Pharmacological importance of stereochemical resolution of enantiomeric drugs.

Authors:  M R Islam; J G Mahdi; I D Bowen
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.228

4.  Studies of verapamil binding to human serum albumin by high-performance affinity chromatography.

Authors:  Rangan Mallik; Michelle J Yoo; Sike Chen; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-10-21       Impact factor: 3.205

5.  Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: local immunosuppressive effects in liver after systemic administration to rats.

Authors:  Anjaneya P Chimalakonda; Reza Mehvar
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.